Lebrun P, Antoine M H, Hermann M, Herchuelz A
Laboratory of Pharmacology, Free University of Brussels, School of Medicine, Belgium.
Eur J Pharmacol. 1991 Jul 23;200(1):159-61. doi: 10.1016/0014-2999(91)90679-k.
Rp 49356, a 'K+ channel opener', inhibited 86Rb outflow, 45Ca outflow and insulin release from glucose-stimulated islets perifused in the presence of Ca2+. The drug lost its capacity to reduce 86Rb outflow in islets exposed to glucose-free or Ca(2+)-free medium. These observations suggest that RP 49356 might exhibit antagonistic actions on B-cell Ca2+ channels. This will, in turn, reduce glucose-stimulated insulin output and Ca(2+)-dependent 86Rb outflow.